mevalonic acid has been researched along with Low Bone Density in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, WZ; Gu, JM; He, JW; Hu, WW; Hu, YQ; Li, M; Liu, YJ; Shao, C; Wang, C; Yue, H; Zhang, H; Zhang, ZL; Zheng, H | 1 |
| Papapoulos, SE | 1 |
1 review(s) available for mevalonic acid and Low Bone Density
| Article | Year |
|---|---|
Catabolic and anabolic signals in bone: therapeutic implications.
Topics: Aging; Bone and Bones; Bone Diseases, Metabolic; Bone Remodeling; Bone Resorption; Diphosphonates; Humans; Mevalonic Acid; Signal Transduction; Tumor Necrosis Factor-alpha | 2001 |
1 other study(ies) available for mevalonic acid and Low Bone Density
| Article | Year |
|---|---|
Genetic polymorphisms in the mevalonate pathway affect the therapeutic response to alendronate treatment in postmenopausal Chinese women with low bone mineral density.
Topics: Aged; Alendronate; Alleles; Asian People; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Female; Haplotypes; Humans; Lumbar Vertebrae; Mevalonic Acid; Osteoporosis; Phosphotransferases (Alcohol Group Acceptor); Polymorphism, Single Nucleotide; Postmenopause | 2015 |